Liposomal ARA-C
Showing 1 - 25 of >10,000
Acute Lymphocytic Leukemia, Adult Lymphoblastic Lymphoma Trial in United States (DNR, VCR, PEG-asp)
Terminated
- Acute Lymphocytic Leukemia
- Adult Lymphoblastic Lymphoma
- DNR
- +12 more
-
La Jolla, California
- +3 more
Apr 26, 2022
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial (Azacitidine, Biospecimen Collection, Bone Marrow Aspiration)
Not yet recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Azacitidine
- +10 more
- (no location specified)
Jan 13, 2023
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia Arising
Not yet recruiting
- Acute Myeloid Leukemia
- +4 more
- Azacitidine
- +6 more
- (no location specified)
Nov 8, 2022
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Tumor, Acute Myeloid
Not yet recruiting
- Acute Myeloid Leukemia
- +3 more
- Azacitidine
- +6 more
- (no location specified)
Nov 15, 2022
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Blasts 5 Percent or More of Bone Marrow Nucleated Cells,
Terminated
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
- +10 more
- Cytarabine
- +3 more
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Nov 17, 2021
Bioavailability of Vitamin C Trial in Warsaw (Liposomal Vitamin C (Liposovit-C), Traditional Vitamin C)
Completed
- Bioavailability of Vitamin C
- Liposomal Vitamin C (Liposovit-C)
- Traditional Vitamin C
-
Warsaw, PolandMedical University of Warsaw
Apr 25, 2023
Heart Failure Trial in Milan (L-arginine and liposomal vitamin C)
Recruiting
- Heart Failure
- L-arginine and liposomal vitamin C
-
Milan, Lombardia, ItalyFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Sep 12, 2023
MDS, Secondary Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Aachen, Düsseldorf, Jena (Venetoclax, Amsacrine,
Not yet recruiting
- Myelodysplastic Syndromes
- +2 more
- Venetoclax
- +4 more
-
Aachen, NRW, Germany
- +2 more
Mar 29, 2023
Postoperative Pain, Cesarean Section Trial in Charlotte (Liposomal bupivacaine, Bupivacaine HCl)
Suspended
- Postoperative Pain
- Cesarean Section
- Liposomal bupivacaine
- Bupivacaine HCl
-
Charlotte, North CarolinaAtrium Health
Jan 27, 2023
Diffuse Large Cell Lymphoma, Burkitt's Lymphoma, High Grade B-cell Lymphoma Trial in United States (Rituximab, IT Cytarabine)
Completed
- Diffuse Large Cell Lymphoma
- +2 more
- Rituximab
- IT Cytarabine
-
Buffalo, New York
- +4 more
Oct 29, 2021
Intensive Conditioning With Thiotepa Combined With Bu/Flu/Ara-C
Not yet recruiting
- Acute Myeloid Leukemia
- +4 more
- (no location specified)
Nov 1, 2023
Acute Myeloid Leukemia, MDS, Transplant-Related Hematologic Malignancy Trial in Milano (Fludarabine, ARA-C, Treosulfan)
Completed
- Acute Myeloid Leukemia
- +2 more
- Fludarabine
- +3 more
-
Milano, Lombardia, ItalyOspedale San Raffaele
Jul 18, 2022
Recurrent Adult Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Houston (BP1001, BP1001
Completed
- Recurrent Adult Acute Myeloid Leukemia
- +3 more
- BP1001
- BP1001 in combination with LDAC
-
Houston, TexasM. D. Anderson Cancer Center
May 26, 2020
Pharmacokinetics Trial in Klamath Falls (Liposomal vitamin C, 1 gram, Liposomal vitamin C, 2 grams, Liposomal vitamin C, 5
Recruiting
- Pharmacokinetics
- Liposomal vitamin C, 1 gram
- +3 more
-
Klamath Falls, OregonGitte Jensen
Jun 29, 2021
Lymphoma Trial in Houston (Cyclophosphamide, Mesna, Vincristine)
Completed
- Lymphoma
- Cyclophosphamide
- +7 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 2, 2020
Relapsed Adult AML, Refractory AML Trial in Milwaukee (Navitoclax Dose Level -1, Navitoclax Dose Level 0, Navitoclax Dose Level
Not yet recruiting
- Relapsed Adult AML
- Refractory AML
- Navitoclax Dose Level -1
- +10 more
-
Milwaukee, WisconsinFroedtert Hospital & the Medical College of Wisconsin
Aug 17, 2023
Breast Cancer Trial in Guandong (pegylated liposomal doxorubicin (PLD), cyclophosphamide (C), trastuzumab (H))
Recruiting
- Breast Cancer
- pegylated liposomal doxorubicin (PLD)
- +5 more
-
Guandong, Guangdong, ChinaSunyat-sen Memorial Hospital
Feb 17, 2022
Lymphoblastic Leukemia in Children Trial (induction: vincristine, L-asparaginase, dexamethasone, intrathecal Ara-C, intrathecal
Not yet recruiting
- Lymphoblastic Leukemia in Children
- induction: vincristine, L-asparaginase, dexamethasone, intrathecal Ara-C, intrathecal Methotrexate
- +7 more
- (no location specified)
Oct 24, 2023
Lymphoma Trial in Houston (AMG 531, Rituximab, Cyclophosphamide)
Completed
- Lymphoma
- AMG 531
- +8 more
-
Houston, TexasUT MD Anderson Cancer Center
Aug 25, 2021
Acute Myeloid Leukemia Trial in Japan (PF-04449913, Low dose ARA-C (LDAC), Daunorubicin)
Active, not recruiting
- Acute Myeloid Leukemia
- PF-04449913
- +5 more
-
Nagoya, Aichi, Japan
- +8 more
Jan 12, 2022
Acute Myeloid Leukemia (Relapsed/Refractory) Trial in Frankfurt am Main, Hannover, Hamburg (Selinexor, Idarubicin, Cytarabine)
Completed
- Acute Myeloid Leukemia (Relapsed/Refractory)
- Selinexor
- +2 more
-
Frankfurt am Main, Hessen, Germany
- +2 more
Aug 1, 2021